Nature's Sunshine Product... (NATR)
| Bid | 11.01 |
| Market Cap | 223.65M |
| Revenue (ttm) | 454.36M |
| Net Income (ttm) | 7.7M |
| EPS (ttm) | 0.4 |
| PE Ratio (ttm) | 30.25 |
| Forward PE | 18.31 |
| Analyst | Buy |
| Ask | 13 |
| Volume | 68,462 |
| Avg. Volume (20D) | 39,408 |
| Open | 12.39 |
| Previous Close | 12.05 |
| Day's Range | 12.10 - 12.66 |
| 52-Week Range | 10.81 - 19.92 |
| Beta | 1.05 |
About NATR
Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascul...
Analyst Forecast
According to 2 analyst ratings, the average rating for NATR stock is "Buy." The 12-month stock price forecast is $19.5, which is an increase of 61.16% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · seekingalpha.com
Nature's Sunshine Products, Inc. (NATR) Q4 2024 Earnings Call TranscriptNature's Sunshine Products, Inc. (NASDAQ:NATR ) Q4 2024 Results Conference Call March 11, 2025 5:00 PM ET Company Participants Nate Brower - General Counsel Terrence Moorehead - Chief Executive Office...